Philadelphia Jury Awards Indiana Woman $12.5 Million Over Ethicon Prolift Pelvic Mesh Implant
After trial: Ethicon and Johnson & Johnson appealed. The Pennsylvania Superior Court affirmed in June 2018, and the Pennsylvania Supreme Court affirmed on jurisdiction in October 2020, so the judgment stood.
Won by Kline & Specter, PC.
In December 2015 a Philadelphia jury awarded Patricia Hammons, an Indiana woman implanted with Ethicon's Prolift pelvic mesh kit in 2009, $12.5 million, made up of $5.5 million in compensatory damages and $7 million in punitive damages. The jury found that Ethicon knew of the risk of pain during intercourse before launch and did not warn of it. The Pennsylvania Superior Court affirmed in 2018, and the Pennsylvania Supreme Court upheld Pennsylvania's jurisdiction over Ethicon in 2020, leaving the judgment in place.
What happened
Patricia Hammons, an Indiana woman who worked stocking shelves at a Walmart, was implanted with Ethicon's Prolift pelvic mesh kit in 2009 to treat pelvic organ prolapse. The device was made by Ethicon, a Johnson & Johnson subsidiary, and sold from its launch in 2005 until it was pulled from the market in 2012.
After the implant, Hammons had sharp pain during intercourse and stopped having sex. In 2012 a urogynecologist traced her symptoms to the mesh, and over three surgeries he cut mesh out of her vaginal wall and her bladder, where it had worked into the bladder wall, and repaired two holes in her bladder. She was left with ongoing incontinence and a shortened, scarred vagina, and she has abstained from sex because of the pain.
She sued in the Philadelphia Court of Common Pleas, and her case went to trial in late 2015 as the first pelvic mesh trial against Ethicon in that court. It ran about two and a half weeks. Her lawyers argued that the Prolift was defectively designed and that Ethicon had not given patients or doctors an adequate warning. Her expert witnesses, a gynecologist and a urogynecologist, testified that the design was defective.
The jury heard that Ethicon knew before the product launched that mesh implants could cause pain during sex, yet the risk was not made clear in the product's instructions for use or in patient brochures. An Ethicon engineer acknowledged on the stand that the company had never developed a procedure for removing the mesh, even though it knew implants could fail. Shanin Specter of Kline & Specter told the Philadelphia Inquirer after the verdict that every American depends on Johnson & Johnson to put safety ahead of selling. Ethicon's lawyer told jurors the company had made mistakes but argued that its employees never meant to cause harm.
On December 22, 2015, the jury returned a verdict of $12.5 million: $5.5 million in compensatory damages and $7 million in punitive damages. The trial court then added delay damages calculated on the compensatory award only, which brought the total judgment to $12,850,945.18.
Ethicon and Johnson & Johnson appealed. Charles L. Becker argued for Hammons, and on June 19, 2018, the Pennsylvania Superior Court affirmed the judgment. The Pennsylvania Supreme Court took the case on the question of whether Pennsylvania courts could exercise jurisdiction over the New Jersey defendants for an Indiana plaintiff's injury. On October 21, 2020, it ruled 6 to 1 that they could, because Ethicon had been involved in the production in Pennsylvania of the mesh Hammons claimed injured her.
Sources
This account is drawn from contemporaneous public reporting and the court record.
- 1.Philadelphia Inquirer, 'Phila. jury awards $12.5M in vaginal mesh case', Dec. 22, 2015·Archived copy
- 2.Pa. Superior Court, Hammons v. Ethicon, Inc., 190 A.3d 1248, June 19, 2018
- 3.Leagle, Hammons v. Ethicon, Inc., 190 A.3d 1248 (Pa. Super. 2018), June 19, 2018·Archived copy
- 4.Pa. Supreme Court, Hammons v. Ethicon, Inc., No. 7 EAP 2019, Oct. 21, 2020
More proven verdicts from Kline & Specter, PC
All Kline & Specter, PC proven verdicts →As chair of the plaintiffs' negotiating committee and Liaison Counsel in the Vioxx multidistrict litigation, Russ Herman directed the negotiations that produced a $4.85 billion settlement with Merck resolving approximately 45,000 to 50,000 personal-injury claims.
A Philadelphia jury found that Monsanto failed to warn that Roundup could cause cancer and awarded John McKivison $2.25 billion. The trial judge later reduced the award to $400 million.
After Amtrak Train 188 derailed in Philadelphia in May 2015, killing eight and injuring more than 200, Kline & Specter's Thomas R. Kline led the plaintiffs' negotiations that produced a $265 million settlement fund for the victims.
A Philadelphia jury found the Hospital of the University of Pennsylvania liable for the brain injury a newborn suffered when staff delayed a cesarean section, a $182.7 million verdict that grew to a molded judgment of about $207.6 million, the largest medical malpractice award in Pennsylvania history. Kline & Specter argued and won the appeal, where the Pennsylvania Superior Court affirmed the full $207.6 million judgment in July 2025.
Related product liability verdicts
Leroy Rice, a forklift operator, was left permanently paralyzed on September 18, 2001, when a storage racking system at his Philadelphia warehouse job collapsed and dropped roughly a ton of frozen food on him. A Philadelphia jury awarded him $12,400,000 at a second trial in 2010, after the Superior Court reversed the first trial's judgment and ordered a new trial on damages, and the trial court molded that verdict to $17,339,797.30 to add delay damages. The Pennsylvania Superior Court affirmed the judgment against racking manufacturer Interlake Material Handling Inc. on February 22, 2012, according to contemporaneous legal-press coverage. Thomas J. Duffy Jr. is named in the trial court's opinion as counsel for Rice.
A Philadelphia jury awarded Donna Kendall $6.3 million in compensatory damages and $28 million in punitive damages after finding that Wyeth's Prempro hormone-replacement drug caused her breast cancer and the double mastectomy that followed; the Pennsylvania Superior Court restored the full punitive award in 2012 after the trial judge had cut it to $1 million.
A Philadelphia jury returned a $3.5 million verdict for Kelly Martel in December 2023, finding Monsanto's Roundup weed killer caused her non-Hodgkin lymphoma after more than fifteen years of exposure. The Pennsylvania Superior Court affirmed the judgment in full in 2025.